In its seventh annual progress report on cancer, the American Association for Cancer Research made the following policy recommendations:
FDA granted accelerated approval to Aliqopa (copanlisib) for the treatment of adults with relapsed follicular lymphoma who have received at least two prior systemic therapies.
FDA approved Mvasi (bevacizumab-awwb) as a biosimilar to Avastin (bevacizumab) for the treatment of multiple types of cancer. Mvasi is the first biosimilar approved in the U.S. for the treatment of cancer.
Regeneron Pharmaceuticals Inc. and Sanofi said FDA has granted Breakthrough Therapy designation status to cemiplimab, an investigational human, monoclonal antibody targeting PD-1– (REGN2810) for the treatment of adults with metastatic cutaneous squamous cell carcinoma and adults with locally advanced and unresectable CSCC.
A new welcome center at Sidney Kimmel Cancer Center at Thomas Jefferson University will be officially open Oct. 2. The addition is a part of the cancer center’s patient support system. There, patients and families will be introduced to supportive care services and cancer-related information. The resources are aimed at educating those affected, fostering a... […]
Roswell Park Cancer Institute joined joined the Oncology Information Exchange Network (ORIEN), a network of centers collaborating to share information and translate pooled resources into personalized treatments for cancer patients. With Roswell Park, the number of ORIEN members has expanded to 16. Formed in 2014, ORIEN seeks to give oncologists ready access to a searchable... […]
Adam Marcus, director of Emory University’s Integrated Cellular Imaging Shared Resource, has been appointed as Winship Cancer Institute’s new associate director for basic research and shared resources. He replaces Paul Doetsch, who served in the position since 1999. Doetsch has been designated to become the deputy scientific director in the Division of Intramural Research of... […]
NRG Oncology, one of the five funded network groups within NCI’s National Clinical Trials Network said Robert Mannel will serve as one of its three group chairmen. He joins Walter Curran and Norman Wolmark as the NRG Oncology group chairmen and principal investigators of the group’s federal awards. Mannell, director of the Stephenson Cancer Center,... […]
James Allison and Robert Schreiber won the Balzan Prize for their contributions to immunological approaches in cancer therapy. According to the prize committee, “Professors Schreiber and Allison have played transformative roles in the field of tumor immunology, Schreiber by demonstrating that the immune system is crucially involved in fighting tumours and by introducing the concept... […]
David Penson, chair of the Department of Urologic Surgery at Vanderbilt University Medical Center, was named associate editor of The Journal of the National Cancer Institute. Penson, the Paul V. Hamilton and Virginia E. Howd Professor in Urologic Oncology, also serves as director of the Center for Surgical Quality and Outcomes Research at Vanderbilt University... […]
